evidencegaps
Primary study · included by 1 review

Salivary evaluation in radioactive I131 treated patients with thyroid carcinoma.

Daniel 2018 · Daniel Filipe Ivan, Lima Luiza Dutra, Grando Liliane Janete, et al. · Acta odontologica Scandinavica · 2018

Included by

Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer.
Non-Cochrane · prognostic · 2026 · cited as Daniel 2018 · Supplementary Table S3 (included studies); Figs. 1-3
Outcome this study informsPooled effectEvidenceCertainty
Xerostomia (pooled prevalence)
Radioiodine (I131) therapy · within 2 months after RIT
Prevalence 0.60 [0.28, 0.85]3 studies · 1502 participantsGRADE not reported

1 including review in total.